Gaelle Munsch

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Genomic Evidence Links Inflammation to Residual Pulmonary Vascular Obstruction and Risk of Pulmonary Embolism Recurrence.

Genomic Evidence Links Inflammation to Residual Pulmonary Vascular Obstruction and Risk of Pulmonary Embolism Recurrence.

Journal: medRxiv : the preprint server for health sciences

Published: July 17, 2026

Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project.

Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project.

Journal: Thrombosis and haemostasis

Published: July 14, 2026

Risk of venous thromboembolism in first-degree relatives of affected patients compared with general population.

Risk of venous thromboembolism in first-degree relatives of affected patients compared with general population.

Journal: Thrombosis research

Published: April 27, 2026

Genetic associations with pulmonary embolism among those with a deep vein thrombosis: the INVENT Consortium.

Genetic associations with pulmonary embolism among those with a deep vein thrombosis: the INVENT Consortium.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 05, 2026

Impact of ABO blood groups on residual pulmonary vascular obstruction in patients with unprovoked pulmonary embolism.

Impact of ABO blood groups on residual pulmonary vascular obstruction in patients with unprovoked pulmonary embolism.

Journal: Blood vessels, thrombosis & hemostasis

Published: October 22, 2025

Genomics of Long-Term Complications of Childhood Leukemia: Rationale and Design of the GenLEA Study.

Genomics of Long-Term Complications of Childhood Leukemia: Rationale and Design of the GenLEA Study.

Journal: Pediatric blood & cancer

Published: September 30, 2025

Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes.

Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes.

Journal: medRxiv : the preprint server for health sciences

Published: December 16, 2024

Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies.

Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies.

Journal: eLife

Published: December 12, 2024

Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes.

Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes.

Journal: Blood

Published: December 06, 2024

Genome-Wide Search for Nonadditive Allele Effects Identifies PSKH2 as Involved in the Variability of Factor V Activity.

Genome-Wide Search for Nonadditive Allele Effects Identifies PSKH2 as Involved in the Variability of Factor V Activity.

Journal: Journal of the American Heart Association

Published: October 18, 2024

A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor.

A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor.

Journal: Blood

Published: September 20, 2024

Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism.

Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 21, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026